Bartlomiejczyk, Marcin Adam
Penson, Peter
Banach, Maciej
Funding for this research was provided by:
The Medical University of Lodz
Article History
First Online: 25 January 2019
Compliance with Ethical Standards
:
: Maciej Banach has served on the speakers bureau of Abbott/Mylan, Abbott Vascular, Actavis, Akcea, Amgen, Biofarm, KRKA, MSD, Sanofi-Aventis, Servier, and Valeant and has served as a consultant to Abbott Vascular, Akcea, Amgen, Daichii Sankyo, Esperion, Lilly, MSD, Resverlogix, Sanofi-Aventis; grants from Sanofi and Valeant; Peter Penson owns four shares in AstraZeneca PLC and receives Speaker’s fees from Amgen Inc.; Marcin A. Bartlomiejczyk has no conflicts of interest to disclosure.
: This article does not contain any studies with human or animal subjects performed by any of the authors.